For more than 20 years, hormone therapy for menopause has carried a warning label from the Food and Drug Administration ...
The FDA’s new Commissioner’s National Priority Voucher signals a transformative shift in U.S. drug review, tying accelerated approval to manufacturing readiness, domestic supply-chain strength, and ...
The Democrats weakened the borders, allowing Mexican drug cartels to smuggle fentanyl into the United States, where it ...
Drug & Device Team provides recommendations based on Food & Drug Administration (FDA) draft guidance on Quality Management System ...
US FDA approves Henlius and Organon’s Poherdy, the first Perjeta biosimilar: Shanghai Tuesday, November 18, 2025, 16:00 Hrs [IST] Shanghai Henlius Biotech, Inc., a global health ...
The Food and Drug Administration (FDA) has cautioned the public not to buy or sell any health product that does not have FDA ...
Pharmaceutical Technology on MSNOpinion
FDA inspection reveals critical supply chain vulnerabilities
Amanda Murphy, Senior Director at GlobalData, discusses how real-time intelligence can turns regulatory events into ...
In recent months, Morocco has witnessed an unprecedented surge in public debates about food quality and safety. At the heart ...
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for POHERDY® ...
Quality, stability, sustainability, and the increased and thoughtful integration of artificial intelligence are foremost in the minds of those on the leading edge of testing trends.
Shoppers Drug Mart billed the Ontario government’s MedsCheck program $81.2 million for medication reviews over a two-year ...
The Food and Drug Administration (FDA) has issued new draft guidance signaling a policy shift toward reducing the need for comparative efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback